We also discovered genetic “hotspots” that could impact TF binding and gene expression, potentially contributing to tissue-specific disorders such as heart disease, type 2 diabetes, and prostate cancer (Fogarty et al. 2014; Huang et al. 2014; Reschen et al. 2015). This evidence concerns the gene TF and Familial prostate cancer.